Antonio Chiesi, MD

Biography

Board-level executive with over 30 years of experience leading research teams in public and private research organizations and over 15 years of experience leading highly innovative companies, life sciences businesses, public and private fundraising for technology-based companies, and returning value to shareholders.

Expert and Consultant in the EV field. Founder and CEO of three biotech Companies, Exosomics, HansaBioMed Life Sciences, and LongEVity Bioscience.

Exosomics’ focus is on leveraging EVs for innovative diagnostic and therapeutic approaches. Exosomics, having sold its CDMO activity to Lonza in 2021, now leads a group of companies active in various areas of the EV field.

HansaBioMed LS is the oldest exosome-focused company worldwide (established in 2007 in Tallinn). It is currently the leader in the exosome arena with the most extensive catalogue of products and services specifically designed for EV/exosomes research on the market.

LongEVity Bioscience was established in 2024 and is currently based in Siena (Tuscany). The company is actively offering high-quality plant-derived exosomes as active ingredients and ready-to-use products for the cosmetic and food supplement markets.